Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didierlaurent

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Validation of quantitative, allergen-specific ELISAsWolf-Meinhard Becker, Ronald van Ree, Helmut Fiebig, et al.
NPJ Vaccines|July 7, 2018
Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory propertiesCharlotte Givord, Iain Welsby, Sophie Detienne, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 13, 2019
<sup>18</sup>F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosisMukedaisi Abulizi, Islem Sifaoui, Mijiti Wuliya-Gariepy, et al.
Frontiers in Immunology|September 1, 2017
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in HumansWivine Burny, Andrea Callegaro, Viviane Bechtold, et al.
Plos One|May 16, 2015
Pectate lyase pollen allergens: sensitization profiles and cross-reactivity patternUlrike Pichler, Michael Hauser, Martin Wolf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyNatacha Madelon, Kim Lauper, Gautier Breville, et al.
Human Vaccines & Immunotherapeutics|October 14, 2024
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunityUte Klinkardt, Mirjam Schunk, John Ervin, et al.
JAMA Neurology|February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With OcrelizumabNatacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
Vaccine|March 10, 2019
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humansWivine Burny, Arnaud Marchant, Caroline Hervé, et al.
Communications Medicine|November 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over timeJohan Schwab, Mathilde Foglierini, Eva Pescosolido, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Validation of quantitative, allergen-specific ELISAsWolf-Meinhard Becker, Ronald van Ree, Helmut Fiebig, et al.
NPJ Vaccines|July 7, 2018
Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory propertiesCharlotte Givord, Iain Welsby, Sophie Detienne, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 13, 2019
<sup>18</sup>F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosisMukedaisi Abulizi, Islem Sifaoui, Mijiti Wuliya-Gariepy, et al.
Frontiers in Immunology|September 1, 2017
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in HumansWivine Burny, Andrea Callegaro, Viviane Bechtold, et al.
Plos One|May 16, 2015
Pectate lyase pollen allergens: sensitization profiles and cross-reactivity patternUlrike Pichler, Michael Hauser, Martin Wolf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyNatacha Madelon, Kim Lauper, Gautier Breville, et al.
Human Vaccines & Immunotherapeutics|October 14, 2024
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunityUte Klinkardt, Mirjam Schunk, John Ervin, et al.
JAMA Neurology|February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With OcrelizumabNatacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
Vaccine|March 10, 2019
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humansWivine Burny, Arnaud Marchant, Caroline Hervé, et al.
Communications Medicine|November 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over timeJohan Schwab, Mathilde Foglierini, Eva Pescosolido, et al.
Pageof 15